Introduction
============

The World Health Organization defines stroke as a rapidly developing clinical syndrome of focal or global (in the case of coma) disturbance of cerebral function lasting longer than 24 hours or leading to death with no apparent cause other than vascular origin.[@b1-ijgm-8-349] Stroke is a leading cause of morbidity and mortality worldwide.[@b2-ijgm-8-349],[@b3-ijgm-8-349] Stroke incidence in Nigeria and other Sub-Saharan African countries is on the increase.[@b4-ijgm-8-349] Factors driving this transition include changes in diet, cigarette smoking, alcohol consumption, inadequate exercise, and increase in the prevalence of obesity, and also increase in other noncommunicable diseases such as hypertension and diabetes mellitus.[@b5-ijgm-8-349]

Neuroimaging techniques, especially the computerized tomography (CT) scan or magnetic resonance imaging, remain the most reliable tools for diagnosing stroke types.[@b6-ijgm-8-349]--[@b8-ijgm-8-349] However, these imaging modalities are not readily available in Nigeria, especially in rural communities, and when available, they are not easily affordable due to the prevailing poverty and high cost.[@b2-ijgm-8-349],[@b9-ijgm-8-349] The unavailability of CT scan in a good majority of the hospitals in Nigeria, in addition to the prohibitive cost of the imaging, makes the use of weighted clinical scoring systems like Siriraj Stroke Score (SSS),[@b10-ijgm-8-349] Besson Stroke Score,[@b11-ijgm-8-349] and Allen Stroke Score[@b8-ijgm-8-349] imperative in making a diagnosis of stroke types in the country. SSS is most commonly used in Nigeria, probably because it is easy to calculate by the bedside of patients.

There are limited prospective validation studies for stroke scores in Sub-Saharan African countries. In Nigeria, the three previously published prospective studies on SSS reported variable conclusions,[@b9-ijgm-8-349],[@b12-ijgm-8-349],[@b13-ijgm-8-349] thus necessitating more studies. In addition, these three prospective studies were carried out in the western and northern parts of Nigeria. There is currently no published prospective study from eastern Nigeria, prompting us to undertake this study.

Method
======

The study was a 2-year prospective study conducted between November 2011 and October 2013 at Federal Medical Centre, Umuahia, Abia state, southeast Nigeria. Ethical clearance was obtained from the Federal Medical Centre Ethics Committee. The hospital is a tertiary center and receives referral from other hospitals in the state and from neighboring states as well. Subjects with clinical diagnosis of stroke and aged 18 years and above, who had brain CT scan done within 14 days of onset of symptoms, were recruited. Subjects with repeat or recurrent stroke were excluded from the study and so were those who performed their CT scan investigation after 14 days from the onset of features of stroke. Also excluded from the study were subjects on anticoagulant therapy prior to the episode of stroke, those with bilateral motor weakness, those with CT scan evidence of subarachnoid hemorrhage, and patients who died or left the hospital in less than 24 hours after admission.[@b2-ijgm-8-349] An interviewer structured questionnaire was administered and relevant data were collected. These include patient's age, sex, duration of symptoms before presentation, and whether the patient is a known diabetic or hypertensive. In addition, the first recorded blood pressure from onset of the stroke, consciousness level based on Glasgow Coma Scale, presence of atheroma marker, and the presence of headache or vomiting within 2 hours of onset were documented. The clinical diagnosis of stroke type was recorded by a consultant physician and the reports of CT scan by a consultant radiologist.

The SSS was calculated using the formula: (2.5× level of consciousness) +(2× headache) +(2× \[vomiting\] +\[0.1× diastolic blood pressure\] --12--\[3× atheroma marker\]). A score \<--1 was taken to suggest infarction, a score \>+ 1 was taken to suggest hemorrhage, while a score of −1 to +1 was considered indeterminate.[@b11-ijgm-8-349] The SSS calculation is as shown in [Table 1](#t1-ijgm-8-349){ref-type="table"}.

Angina pectoris, diabetes mellitus, intermittent claudication, and history of transient ischemic attack were taken as atheroma markers.[@b10-ijgm-8-349]

A previous history of diabetes or a fasting plasma glucose of 126 mg/dL or more, and impaired fasting glucose defined as fasting plasma glucose of 100--125 mg/dL or a random blood glucose of 180 mg/dL or higher was classified as diabetes mellitus.[@b14-ijgm-8-349]

Patients presenting with systolic blood pressure 140 mmHg and above or diastolic blood pressure 90 mmHg and above or who had normal blood pressure but were pharmacologically being treated for hypertension were categorized as hypertensive.[@b14-ijgm-8-349]

Data analysis
-------------

Data were analyzed using statistical package for social sciences (SPSS) version 20.0 (IBM Corporation, Armonk, NY, USA).

Results
=======

Two thousand three hundred and seven adult subjects were admitted into the medical wards during the 2-year period of the study. Three hundred and sixty subjects (15.6%) were stroke subjects. One hundred and thirteen (31.4%) of the 360 subjects admitted with the diagnosis of stroke satisfied the inclusion criteria for our study. The mean age of our study population was 66.5±2.6 years. The interval from ictus (brain attack) to presentation ranged from 1 to 12 days, with a mean of 2.5±0.4 days. Sixty-three (55.8%) subjects presented to the hospital within 24 hours of onset of symptoms. Seventy-four (65.5%) of the 113 subjects had ischemic stroke, while 39 (34.5%) had hemorrhagic stroke.

SSS was significantly predictive of brain infarction in 60 (81.1%) ischemic stroke subjects with brain CT scan diagnosis of ischemic stroke (*P*\<0.05). In subjects with hemorrhagic stroke, SSS was also accurately predictive of intracerebral hemorrhage in 36 (92.3%) subjects with hemorrhage stroke (*P*\<0.05). The SSS was indeterminate in 17 subjects (15 ischemic stroke subjects and 2 acute hemorrhagic stroke subjects).

Subjects were stratified on the basis of age range and sex. The incidence of ischemic and hemorrhagic stroke was more common among the age range 60--69 years; 23 (31.1%) ischemic stroke subjects and 11 (28.95%) hemorrhagic stroke subjects respectively were in this age range. There was no case of ischemic stroke in the age range of 30--39 years; however, three had hemorrhagic stroke in this age group. There were no cases of hemorrhagic stroke in the age ranges of 90--99 and 100--109 years. However, four patients and one patient in these age ranges, respectively, had acute ischemic stroke.

In stratification by sex, 47 (63.5%) males and 27 (36.5%) females had ischemic stroke, while 16 (41.0%) males and 23 (59.0%) females had hemorrhagic stroke. The result showed that more males had acute ischemic stroke, while more females had hemorrhagic stroke (*P*\<0.05).

Among subjects with acute ischemic stroke, 56 (75.7%) were hypertensive, while in acute hemorrhagic stroke, 28 (71.8%) were hypertensive. In addition, with regard to diabetes mellitus, 29 (39.2%) of those with ischemic stroke, and 4 (10.3%) of those with acute hemorrhagic stroke were diabetes mellitus subjects.

Among the clinical features of stroke, occurrence of headache was significantly associated with a diagnosis of cerebral hemorrhage when compared with ischemia. Other significant predictors of cerebral hemorrhage include diastolic blood pressure \>90 mmHg, presence of coma (*P*\<0.05), vomiting (*P*\<0.05), mean arterial pressure \>110 mmHg (*P*\<0.05), and systolic blood pressure \>180 mmHg (*P*\<0.05). Atheroma markers were highly predictive of cerebral ischemic stroke (*P*\<0.05) ([Table 2](#t2-ijgm-8-349){ref-type="table"}).

Among the subjects with acute ischemic stroke, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of SSS were 92%, 94%, 97%, 86%, and 93%, respectively. Among the subjects with hemorrhagic stroke, the sensitivity, specificity, PPV, NPV, and accuracy of SSS were 94%, 92%, 86%, 97%, and 93%, respectively.

Discussion
==========

This is the first prospective study on validity of SSS from the eastern region of Nigeria. The sample size in this study is larger when compared with any of the previous prospective studies emanating from Nigeria. The result showed that 360 (15.6%) of the subjects admitted into the medical wards of the hospital during the study period had stroke. In addition, only 113 (31.4%) of the 360 patients could afford CT scan. The low use of CT scan by the stroke subjects points to its unaffordability to the majority of the subjects. The result also showed that SSS was highly predictive of both acute ischemic stroke and acute hemorrhagic stroke, achieving PPV of 97% and 86%, respectively, with an overall predictive accuracy of 93%. This overall predictive accuracy is higher than the values reported in southwest Nigeria (80%)[@b9-ijgm-8-349] and northeast Nigeria (84.6%).[@b12-ijgm-8-349] However, the predictive accuracy observed by Salawu et al[@b13-ijgm-8-349] also from northeast Nigeria and by Connor et al[@b15-ijgm-8-349] from South Africa was much lower than that observed in this study. A reason for this in the Salawu et al[@b13-ijgm-8-349] study may be the small sample size (about half our sample size). The reason for the difference in the Connor et al[@b15-ijgm-8-349] study is not certain.

The findings in this study that 66.4% of the patients had ischemic stroke, while 33.6% of the patients had hemorrhagic stroke are in keeping with those of earlier studies on stroke in Nigeria.[@b16-ijgm-8-349]--[@b18-ijgm-8-349]

Among the patients with acute ischemic and hemorrhagic stroke, 56 (75.7%) and 28 (71.8%), respectively, had hypertension, while 29 (39.2%) and 4 (10.3%), respectively, had diabetes mellitus. This finding showed that hypertension is a major risk factor for both types of stroke, while diabetes mellitus is a stronger risk factor for ischemic stroke than for hemorrhagic stroke. These findings are similar to those of other prospective studies in other African countries.[@b19-ijgm-8-349]--[@b21-ijgm-8-349]

Headache and vomiting were found to be predictive of hemorrhagic stroke, which is in keeping with the study carried out by Kolapo et al.[@b9-ijgm-8-349] In addition, diastolic blood pressure greater than 90 mmHg was also predictive of acute hemorrhagic stroke. Atheroma marker was predictive of acute ischemic stroke in this study, but not in the study by Kolapo et al.[@b9-ijgm-8-349] Nyandaiti and Bwala[@b12-ijgm-8-349] reported diastolic blood pressure greater than 110 mmHg as a discriminant variable in differentiating cerebral infarction from cerebral hemorrhage, which is similar to the findings in this study.

Sixty-three (55.8%) subjects with acute ischemic and acute hemorrhagic stroke presented within 24 hours of onset of features of stroke. The higher percentage of subjects that presented within the first 24 hours from ictus underlines the need for accurate diagnosis of the stroke type to enable the commencement of appropriate treatment with thrombolytics. However, to facilitate accurate diagnosis of stroke, CT scan should be made available at affordable cost in most hospitals in Nigeria. This need cannot be overemphasized. The management of the tertiary and secondary hospitals, and the government should make every effort to have this facility in their hospitals at affordable cost.

Conclusion
==========

This study showed that SSS is fairly reliable in differentiating acute ischemic stroke from acute hemorrhagic stroke, but efforts should be made by the government and other agencies to make neuroimaging available and affordable in resource poor settings, as critical decisions cannot be made in acute stroke without imaging. Neuroimaging remains the gold standard in diagnosing stroke types.

Limitations
===========

1.  The sample size is relatively small. A larger sample size, preferably involving many centers, is desirable.

2.  A large proportion did not have CT scan done and were thus excluded. This could have affected the result of the study.
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###### 

Calculation of SSS

  Variable                                      Clinical feature      Score
  --------------------------------------------- --------------------- -------
  Consciousness (based on Glasgow Coma Scale)   15 or no alteration   0×2.5
  9--14                                         1×2.5                 
                                                3--8                  2×2.5
  Vomiting                                      No                    0×2
                                                Yes                   1×2
  Headache (within 2 hours)                     No                    0×2
                                                Yes                   1×2
  Diastolic blood pressure (mmHg)                                     ×0.1
  Atheroma markers                              None                  0×3
                                                One or more           1×3
  Constant                                                            −12

**Abbreviation:** SSS, Siriraj Stroke Score.

###### 

Relevant biodata and clinical features of the subjects

                                    CT scan finding   Total        *P*-value    
  --------------------------------- ----------------- ------------ ------------ -------
  Age (years)                                                                   
   30--39                           0 (0%)            3 (7.7%)     3 (2.7%)     
   40--49                           3 (4.1%)          7 (17.9%)    10 (8.8%)    
   50--59                           13 (17.6%)        9 (23.1%)    22 (19.5%)   
   60--69                           23 (31.1%)        11 (28.1%)   34 (30.1%)   
   70--79                           16 (21.6%)        4 (10.3%)    20 (17.7%)   
   80--89                           14 (18.9%)        5 (12.8%)    19 (16.8%)   
   90--99                           4 (5.4%)          0 (0%)       4 (3.5%)     
   100--109                         1 (1.4%)          0 (0%)       1 (0.9%)     
   Total                            74 (100%)         39 (100%)    113 (100%)   
  Sex                                                                           
   Female                           27 (36.5%)        23 (59%)     50 (44.2%)   0.022
   Male                             47 (63.5%)        16 (41%)     63 (55.8%)   
   Total                            74 (100%)         39 (100%)    113 (100%)   
  GCS                                                                           
   3--8                             11 (14.9%)        16 (41%)     27 (23.9%)   0.002
   9--14                            6 (8.1%)          6 (15.4%)    12 (10.6%)   
   15                               57 (77%)          17 (43.6%)   74 (65.5%)   
   Total                            74 (100%)         39 (100%)    113 (100%)   
  Hypertension                                                                  
   Present                          56 (75.7%)        28 (71.8%)   84 (74.3%)   0.653
   Absent                           18 (24.3%)        11 (28.2%)   29 (25.7%)   
   Total                            74 (100%)         39 (100%)    113 (100%)   
  Diabetes mellitus                                                             
   Present                          29 (39.2%)        4 (10.3%)    33 (29.2%)   0.001
   Absent                           45 (60.8%)        35 (89.7%)   80 (70.8%)   
   Total                            74 (100%)         39 (100%)    113 (100%)   
  Vomiting                                                                      
   Present                          10 (13.5%)        21 (53.8%)   31 (27.4%)   0.000
   Absent                           64 (86.5%)        18 (46.2%)   82 (72.6%)   
   Total                            74 (100%)         39 (100%)    113 (100%)   
  Headache                                                                      
   Present                          15 (20.3%)        20 (51.3%)   35 (31.0%)   0.001
   Absent                           59 (79.7%)        19 (48.7%)   78 (69.0%)   
   Total                            74 (100%)         39 (100%)    113 (100%)   
  Atheroma marker                                                               
   Present                          44 (59.5%)        9 (23.1%)    53 (46.9%)   0.000
   Absent                           30 (40.5%)        30 (76.9%)   60 (53.1%)   
   Total                            74 (100%)         39 (100%)    113 (100%)   
  Mean arterial pressure (mmHg)                                                 
   \<70                             2 (2.7%)          0 (0.0%)     2 (1.8%)     0.001
   70--110                          32 (43.2%)        4 (10.3%)    36 (31.8%)   
   \>110                            40 (54.1%)        35 (89.7%)   75 (66.4%)   
   Total                            74 (100%)         39 (100%)    113 (100%)   
  Diastolic blood pressure (mmHg)                                               
   ≤90                              43 (58.1%)        8 (20.5%)    51 (45.1%)   0.000
   \>90                             31 (41.9%)        31 (79.5%)   62 (54.9%)   
   Total                            74 (100%)         39 (100%)    113 (100%)   
  Systolic blood pressure (mmHg)                                                
   \<140                            15 (20.3%)        2 (5.1%)     17 (15.0%)   0.002
   140--159                         18 (24.3%)        3 (7.7%)     21 (18.6%)   
   160--179                         14 (18.9%)        6 (15.4%)    20 (17.7%)   
   ≥180                             27 (36.5%)        28 (71.8%)   55 (48.7%)   
   Total                            74 (100%)         39 (100%)    113 (100%)   

**Abbreviations:** CT, computed tomography; GCS, Glasgow Coma Scale.
